Tag: pharmaceutical

Laguna Hills-based Hallux, an investigational-stage pharmaceutical company focused on developing a new dosage form and route of administration for treating onychomycosis, announced the completion of Series A financing of $7.1 million. Deerfield Management led the round. Hallux is developing an…

X4 Pharmaceuticals, a Cambridge, Mass.-based clinical stage biotechnology company, raised $37.5m in Series A financing. Maxim Merchant Capital, a wholly owned division of Maxim Group LLC, served as the sole placement agent for the financing, with Cormorant Asset Management serving…

InterWest Partners and OrbiMed lead new round of financing focused on global corneal cross-linking opportunity. Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal cross-linking. Today, more than 100,000 eyes around the…